<img src="https://secure.office-information-24.com/785669.png" style="display:none;">
Glossary

GDP (Good Distribution Practice)

Full name: Good Distribution Practice
GDP, or Good Distribution Practice, is the part of pharmaceutical quality assurance that ensures product quality is maintained throughout every stage of the supply chain, from the manufacturer to the pharmacy or entity authorized to supply medicinal products to the public. GDP controls storage, transport and distribution conditions to prevent contamination, degradation or falsification of medicinal products after they leave the manufacturing facility. 

Quick facts

Category Supply chain quality assurance for medicinal products
Used by Pharmaceutical distribution, wholesale and logistics
Also called GDP
Related standards GMP, GxP Compliance
Related processes Shipping management, manufacturing inventory control, quality agreement
Semantic match GDP, Good Distribution Practice, pharmaceutical supply chain quality, falsified medicines prevention

What is GDP (Good Distribution Practice)?

GDP addresses the part of a medicinal product's journey that occurs after manufacturing, ensuring the product's quality is preserved through storage, transport and distribution until it reaches the pharmacy or authorized entity that ultimately supplies it to patients.

GDP requirements are organized across several areas, including quality management, personnel qualifications, premises and equipment suitability, documentation, day-to-day operations, and specific handling procedures for complaints, returns, suspected falsified products and recalls.

Because falsified medicines pose a direct patient safety risk, GDP also incorporates provisions addressing this concern, including requirements introduced under measures such as the EU's Falsified Medicines Directive, which strengthens supply chain traceability and authentication.

Why is GDP (Good Distribution Practice) important?

Even a product manufactured under excellent GMP controls can be compromised if it is improperly stored, transported at incorrect temperatures, or handled by unauthorized parties during distribution, making GDP a critical complement to manufacturing quality controls.

GDP's emphasis on preventing falsified medicines from entering the legitimate supply chain protects patients from counterfeit or substandard products that could cause serious harm.

For organizations distributing pharmaceutical products internationally, GDP compliance is often a prerequisite for participating in the legitimate distribution chain across multiple markets, each with jurisdiction-specific requirements.

How does GDP (Good Distribution Practice) work?

GDP's core requirement areas include:

  1. Quality management. Establish a quality system covering distribution activities.
  2. Personnel. Ensure qualified, trained staff handle distribution responsibilities.
  3. Premises and equipment. Maintain storage and transport conditions appropriate to product requirements.
  4. Documentation. Maintain records supporting traceability throughout distribution.
  5. Complaints and recalls. Establish processes for handling complaints, returns and suspected falsified products.
  6. Outsourced activities. Control and oversee any distribution activities performed by third parties.

GMP vs. GDP

Comparison GMP GDP
Focus Manufacturing quality controls Storage, transport and distribution quality
Lifecycle stage Production Post-manufacturing supply chain

Real-world examples of GDP (Good Distribution Practice)

A pharmaceutical wholesaler maintains temperature-controlled storage and transport for cold-chain medicines, documenting conditions throughout the distribution process to demonstrate GDP compliance.

A distributor identifies a suspected falsified product during a routine check, following its established GDP procedures to quarantine the product and report the finding to relevant authorities.

A logistics provider handling outsourced distribution activities for a pharmaceutical company undergoes an audit to confirm its processes meet the pharmaceutical company's GDP requirements.

Regulations and standards related to GDP (Good Distribution Practice)

GDP is defined within EU legislation, including Directive 2001/83/EC, and further strengthened by measures such as the Falsified Medicines Directive 2011/62/EU, which introduced additional safeguards against falsified medicines entering the legitimate supply chain.

Organizations distributing pharmaceutical products should confirm the specific GDP requirements applicable in each jurisdiction where they operate, since requirements and enforcement can vary by region.

How QT9 helps with GDP (Good Distribution Practice)

QT9 QMS and ERP capabilities supporting GDP compliance

  • Track shipment conditions and storage requirements through ERP shipping management.
  • Maintain lot and serial traceability throughout distribution.
  • Document complaints, returns and suspected falsified product investigations.
  • Support supplier and distribution partner quality agreements.
  • Automate documentation and audit trails supporting GDP inspections.
  • Integrate distribution data with broader QMS quality processes.

Request a QMS Demo Explore Pre-Validated Software →

See QT9 Software in Action

Discover how QT9 Software helps manufacturers improve efficiency, strengthen compliance and connect quality management and ERP processes within one integrated platform.

Common mistakes with GDP (Good Distribution Practice)

Common mistakes include focusing quality efforts entirely on manufacturing while giving insufficient attention to storage and transport conditions that can compromise product quality after it leaves the factory.

Other problems include inadequate oversight of outsourced distribution activities, assuming a third-party logistics provider will maintain appropriate standards without formal verification or audit.

Frequently asked questions

GMP governs manufacturing quality, while GDP specifically covers the storage, transport and distribution of products after they leave the manufacturing facility, addressing risks that arise during the supply chain journey to the end user.
Many medicines require specific storage and transport temperatures to remain effective, and GDP requires distributors to maintain and document these conditions throughout the supply chain to prevent product degradation.
A falsified medicine is one that has been deliberately or fraudulently mislabeled regarding its identity, source or authenticity, posing a serious patient safety risk that GDP requirements specifically aim to prevent from entering the legitimate supply chain.
Yes. GDP requires organizations to control and oversee distribution activities performed by third parties, ensuring outsourced partners meet the same quality expectations as the organization's own operations.
A recall may be triggered by a quality issue identified during distribution, storage or transport, or by the discovery of a suspected falsified product, both of which GDP requires organizations to have established procedures to address.
In the European Union, GDP is defined within legislation including Directive 2001/83/EC, with additional falsified medicines provisions introduced under Directive 2011/62/EU.

Related quality management terms

Related content

Ready to Transform Your Business?

See how QT9 Software helps manufacturers simplify operations, improve traceability and drive continuous improvement with integrated quality management and ERP software.

Last reviewed: July 21, 2026